• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卡纳万病患者的临床病程迁延。

Protracted clinical course for patients with Canavan disease.

作者信息

Zelnik N, Luder A S, Elpeleg O N, Gross-Tsur V, Amir N, Hemli J A, Fattal A, Harel S

机构信息

Department of Paediatrics, Carmel Hospital, Haifa, Israel.

出版信息

Dev Med Child Neurol. 1993 Apr;35(4):355-8. doi: 10.1111/j.1469-8749.1993.tb11649.x.

DOI:10.1111/j.1469-8749.1993.tb11649.x
PMID:8335152
Abstract

Before the establishment of N-acetylaspartic aciduria due to aspartoacylase deficiency as the cause of Canavan disease, diagnosis was based on the characteristic clinical features and spongiform encephalopathy, a pathological response shared by a number of other unrelated conditions. Thus confusion exists in the literature about the phenotype of spongiform encephalopathy (Canavan disease), with reports of 'juvenile' and 'congenital' forms, as well as the classical infantile type. In this report, six of 22 patients with infantile-onset Canavan disease survived beyond six years of age. This phenotypical pattern might be the result of better medical management and care, rather than evidence of genetic heterogeneity.

摘要

在因天冬氨酸酰基转移酶缺乏导致的N-乙酰天门冬氨酸尿症被确立为卡纳万病的病因之前,诊断是基于特征性临床特征和海绵状脑病,而海绵状脑病是许多其他不相关病症共有的病理反应。因此,文献中关于海绵状脑病(卡纳万病)的表型存在混淆,有“青少年型”和“先天性”形式以及经典婴儿型的报道。在本报告中,22例婴儿型卡纳万病患者中有6例存活至6岁以上。这种表型模式可能是更好的医疗管理和护理的结果,而非遗传异质性的证据。

相似文献

1
Protracted clinical course for patients with Canavan disease.卡纳万病患者的临床病程迁延。
Dev Med Child Neurol. 1993 Apr;35(4):355-8. doi: 10.1111/j.1469-8749.1993.tb11649.x.
2
Aspartoacylase deficiency and N-acetylaspartic aciduria in patients with Canavan disease.Canavan病患者的天冬氨酸酰基转移酶缺乏症和N-乙酰天冬氨酸尿症。
Am J Med Genet. 1988 Feb;29(2):463-71. doi: 10.1002/ajmg.1320290234.
3
Aspartoacylase deficiency and N-acetylaspartic aciduria in patients with Canavan disease.Canavan病患者的天冬氨酸酰基转移酶缺乏症和N-乙酰天冬氨酸尿症。
Am J Med Genet. 1989 Apr;32(4):550-1. doi: 10.1002/ajmg.1320320425.
4
N-acetylaspartic aciduria in Canavan disease: another proof in two infants.卡纳万病中的N-乙酰天门冬氨酸尿症:两名婴儿的又一病例证明
Neuropediatrics. 1990 Aug;21(3):140-2. doi: 10.1055/s-2008-1071481.
5
Spongy degeneration of the neuraxis (Canavan-van Bogaert disease) and N-acetylaspartic aciduria.神经轴索海绵状变性(卡纳万-范博加特病)和N-乙酰天门冬氨酸尿症
Neuropediatrics. 1989 May;20(2):79-81. doi: 10.1055/s-2008-1071269.
6
Canavan disease: value of N-acetylaspartic aciduria?卡纳万病:N-乙酰天门冬氨酸尿症的价值?
Neuropediatrics. 1991 May;22(2):III.
7
N-acetylaspartate supports the energetic demands of developmental myelination via oligodendroglial aspartoacylase.N-乙酰天门冬氨酸通过少突胶质细胞天冬氨酸酰基转移酶支持发育性髓鞘形成的能量需求。
Neurobiol Dis. 2016 Dec;96:323-334. doi: 10.1016/j.nbd.2016.10.001. Epub 2016 Oct 4.
8
The spectrum of mutations of the aspartoacylase gene in Canavan disease in non-Jewish patients.非犹太裔患者中卡纳万病中天冬氨酸酰基转移酶基因突变谱。
J Inherit Metab Dis. 1999 Jun;22(4):531-4. doi: 10.1023/a:1005512524957.
9
Canavan disease: diagnosis and molecular analysis.卡纳万病:诊断与分子分析
Genet Test. 1997;1(1):21-5. doi: 10.1089/gte.1997.1.21.
10
Biochemical diagnosis of Canavan disease.卡纳万病的生化诊断
Childs Nerv Syst. 1992 Dec;8(8):468-70. doi: 10.1007/BF00274411.

引用本文的文献

1
Oligodendrocyte-targeted adeno-associated virus gene therapy for Canavan disease in children: a phase 1/2 trial.针对儿童卡纳万病的少突胶质细胞靶向腺相关病毒基因治疗:一项1/2期试验。
Nat Med. 2025 Sep 16. doi: 10.1038/s41591-025-03919-w.
2
Cellular and molecular mechanisms of aspartoacylase and its role in Canavan disease.天冬氨酸酰基转移酶的细胞和分子机制及其在卡纳万病中的作用。
Cell Biosci. 2024 Apr 6;14(1):45. doi: 10.1186/s13578-024-01224-6.
3
The pathogenesis of, and pharmacological treatment for, Canavan disease.脑腱黄瘤病的发病机制与药物治疗。
Drug Discov Today. 2022 Sep;27(9):2467-2483. doi: 10.1016/j.drudis.2022.05.019. Epub 2022 May 27.
4
Investigation of the motor system in two siblings with Canavan's disease: a combined transcranial magnetic stimulation (TMS) - diffusion tensor imaging (DTI) study.对两名患有卡纳万病的兄弟姐妹的运动系统进行的研究:一项经颅磁刺激(TMS)与扩散张量成像(DTI)相结合的研究。
Metab Brain Dis. 2017 Apr;32(2):307-310. doi: 10.1007/s11011-017-9955-x. Epub 2017 Jan 28.
5
Long-term follow-up after gene therapy for canavan disease.Canavan 病基因治疗的长期随访。
Sci Transl Med. 2012 Dec 19;4(165):165ra163. doi: 10.1126/scitranslmed.3003454.
6
Mutational analysis of aspartoacylase: implications for Canavan disease.天冬氨酸酰基转移酶的突变分析:对卡纳万病的意义。
Brain Res. 2007 May 7;1148:1-14. doi: 10.1016/j.brainres.2007.02.069. Epub 2007 Mar 3.
7
The frequency of the C854 mutation in the aspartoacylase gene in Ashkenazi Jews in Israel.以色列德系犹太人中天冬氨酸酰基转移酶基因C854突变的频率。
Am J Hum Genet. 1994 Aug;55(2):287-8.